WHO suspends COVID-19 trials of HCQ over safety issues
Team Udayavani, May 26, 2020, 9:43 AM IST
The World Health Organization said that it will briefly drop hydroxychloroquine—the anti-malaria drug from its study into trial COVID-19 medicines on Monday, May 26.
In a press briefing, the WHO chief general Tedros Adhanom Ghebreyesus said that a paper published last week in the Lancet demonstrated that individuals taking hydroxychloroquine were at a higher danger of death and heart issues. Considering that the WHO will temporarily pause the worldwide clinical trial of hydroxychloroquine for COVID-19 treatment.
Tedros stated that hydroxychloroquine and chloroquine are approved medicines for treating Malaria or autoimmune diseases.
“The other medicines in the trial will continue to be tested including the experimental drug remdesivir, and HIV combination therapy,” he added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Trump pits Americans against one another, US deserves better: Kamala Harris
Will end economic disaster of Kamala Harris, launch brand new Trump economic miracle: Donald Trump
‘Kamala, you are fired’, thunders Trump as race for White House remained razor-tight
‘Kamala, you are fired’: Donald Trump at Wisconsin rally
At least 64 people die in devastating flash floods in eastern Spain, officials say
MUST WATCH
Latest Additions
Jayant Patil claims BJP used irrigation ‘scam’ to blackmail Ajit Pawar; Fadnavis, NCP chief hit back
Medical College expels 5 MBBS students from hostel for ragging juniors
Insulting women is in DNA of Cong leaders, alleges Jharkhand BJP
Man arrested from Delhi for calling up Pappu Yadav posing as aide of Lawrence Bishnoi
Tejasvi Surya hits out at Kharge, CMs of Cong-ruled states over poll promises
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.